3-Chloro-2-methylaniline

We are 3-Chloro-2-methylaniline CAS:87-60-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 87-60-5
Product Name: 3-Chloro-2-methylaniline
Other Name:
3-Chloro-2-methylaniline
3-Chloro-2-methylbenzenamine
3-Chloro-o-toluidine
 
Density: 1.2±0.1 g/cm3
Boiling Point: 241.8±20.0 °C at 760 mmHg
Melting Point: 2 °C(lit.)
Molecular Formula: C7H8ClN
Molecular Weight: 141.598
Flash Point: 100.0±21.8 °C
Exact Mass: 141.034531
PSA: 26.02000
LogP: 2.27
Vapour Pressure: 0.0±0.5 mmHg at 25°C
Index of Refraction: 1.585
 
Specification
Appearance: Brown red liquid
3-Chloro-2-methyl-aniline: ≥99.5%
5-Chloro-2-methyl-aniline: ≤0.15%
6-Chloro-2-methyl-aniline: ≤0.15%
6-Chloro-2-nitro-toluene: ≤0.10%
2-Methyl-aniline: ≤0.10%
Water: ≤0.50%
 
Application
Intermediates of Quinclorac CAS: 84087-01-4.
Be used as pesticide intermediate, mainly used in the synthesis of the herbicide Quinclorac.
It is an important raw material for synthetic dyes and pesticides. It can synthesize dye DB-50 and produce paddy field herbicides.
3-Chloro-2-methylaniline, is a versatile organic building block, used for the synthesis of various pharmaceutical compounds, and therapeutic agents. For instance, it is used for the synthesis of 1-[2-(10-dihydroartemisininoxy) ethyl]-3-phenylurea derivatives as potential agents against cancer.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

3-Chloro-2-methylaniline


Related News: In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells.23163-84-0 In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells.2-methyloxolan-3-one CAS:3188-00-9 Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.18591-57-6 Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300.

Related Products
Product Name
2-(2-prop-2-ynoxyethoxy)ethanol Cas:7218-43-1 View Details
dibenzothiophene-2,2′-diboronic acid View Details
Didodecyldimethylammonium bromide Cas:3282-73-3 View Details
3-Nitrophthalonitrile manufacturer (2E,4E)-2,4-Octadienal manufacturer 1,10-Undecadiene manufacturer 3-bromo-3,3-difluoroprop-1-ene Cas:420-90-6 manufacturer Sodium erythorbate Cas:6381-77-7 manufacturer